SNOA
Sonoma Pharmaceuticals, Inc.Company Information
- Company Name
- Sonoma Pharmaceuticals, Inc.
- CIK
- CIK0001367083
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- SNOA: Nasdaq
- Fiscal Year End
- March 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- SNOA
SEC filing data through
Insider Sentiment
- Last purchase
- 2018-03-13
- Last sale
- —
- Shares purchased (TTM)
- 13,455
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 110,782
- Shares outstanding
- 3,846,000
- Ownership
- 2.88%
Earnings Market Reaction
- Filing date
- 2026-08-06
- Price on filing date
- —
- 1-month reaction
- 4.80%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 5 | 2 | 3 | 3 | 4 | 5 | 5 | 4 | 3 | 3 | 2 | 2 | ||||||
| Accounts Receivable Net Current | 3 | 3 | 2 | 3 | 3 | 2 | 2 | 3 | 3 | 3 | 3 | 2 | ||||||
| Inventory Net | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | ||||||
| Prepaid Expense And Other Assets Current | 4 | 3 | 3 | 3 | 3 | 2 | 1 | 2 | 3 | 4 | 4 | 4 | ||||||
| Assets Current | 16 | 12 | 12 | 13 | 13 | 13 | 12 | 12 | 12 | 13 | 13 | 12 | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Right Of Use Asset | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Deferred Income Tax Assets Net | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 18 | 14 | 14 | 14 | 15 | 14 | 14 | 14 | 14 | 15 | 15 | 14 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 2 | 2 | 2 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Accounts Payable And Other Accrued Liabilities | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Deferred Revenue Current | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Long Term Debt Current | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Short Term Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities Current | 5 | 5 | 4 | 4 | 5 | 4 | 4 | 3 | 4 | 4 | 3 | 3 | ||||||
| Deferred Revenue Noncurrent | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Liability Noncurrent | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities | 12 | 11 | 10 | 10 | 11 | 9 | 9 | 8 | 9 | 9 | 8 | 8 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 211 | 207 | 207 | 207 | 207 | 207 | 206 | 206 | 204 | 203 | 203 | 201 | ||||||
| Retained Earnings Accumulated Deficit | -201 | -201 | -200 | -200 | -199 | -198 | -197 | -196 | -195 | -194 | -193 | -192 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -3 | -3 | -3 | -3 | -4 | -4 | -5 | -4 | -4 | -3 | -3 | -3 | ||||||
| Stockholders Equity | 7 | 3 | 3 | 4 | 4 | 4 | 5 | 5 | 5 | 6 | 7 | 6 | ||||||
| Liabilities And Stockholders Equity | 18 | 14 | 14 | 14 | 15 | 14 | 14 | 14 | 14 | 15 | 15 | 14 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | 0.00 | - | - | ||||||
| Preferred Stock Shares Authorized | 1 | 1 | 1 | 1 | 1 | 1 | 1 | - | - | 1 | - | - | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | 0 | - | - | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | 0 | - | - | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 24 | 24 | 24 | 24 | ||||||
| Common Stock Shares Issued | 5 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 13 | ||||||
| Shares Outstanding | 5 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 13 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialSonoma Pharmaceuticals, Inc. (SNOA) — SEC Financial Statements & Analysis
Sonoma Pharmaceuticals, Inc. (SNOA) is a surgical & medical instruments & apparatus company, incorporated in DE. Sonoma Pharmaceuticals, Inc. trades on Nasdaq as: SNOA. Sonoma Pharmaceuticals, Inc. (SNOA)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06. Based on that filing, Sonoma Pharmaceuticals, Inc. carries a market cap of $4.73M, a P/E ratio of -2.09x, a P/B ratio of 0.72x, a P/S ratio of 0.22x, an enterprise value of $-467.42K, and an EV/EBITDA multiple of 0.36x. On profitability, it posts a gross margin of 38.91%, an operating margin of -6.41%, a net margin of -10.33%, a Return on Equity (ROE) of -42.52%, a Return on Assets (ROA) of -13.85%, and a Return on Invested Capital (ROIC) of -103.28%. Per share, it reports EPS of $-0.59, diluted EPS of $-0.59, free cash flow per share of $-0.69, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 47.00% year-over-year, net income growth of -36.32% year-over-year, and EPS growth of -72.83% year-over-year. On the balance sheet, it maintains a current ratio of 2.99x, a quick ratio of 1.56x, working capital of $10.82M, a debt-to-equity ratio of 1.75x, a debt ratio of 0.64, an interest coverage ratio of -370.17x, free cash flow of $-2.65M (TTM), and net debt of $-5.20M. Figures sourced from SEC EDGAR.
- Market Cap
- $4.73M
- P/E TTM
- -2.09x
- EPS TTM
- $-0.59
- P/B TTM
- 0.72x
- ROE TTM
- -42.52%
- ROA TTM
- -13.85%
- Debt To Equity
- 1.75x
- Free Cash Flow TTM
- $-2.65M
- Net Revenue TTM Growth 1Y
- 47.00%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Sonoma Pharmaceuticals, Inc. in?
Sonoma Pharmaceuticals, Inc. (SNOA) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does SNOA trade on?
Sonoma Pharmaceuticals, Inc. (SNOA) trades on the Nasdaq.
Where is Sonoma Pharmaceuticals, Inc. incorporated?
Sonoma Pharmaceuticals, Inc. is incorporated in DE.
When was Sonoma Pharmaceuticals, Inc. (SNOA)'s most recent SEC filing?
Sonoma Pharmaceuticals, Inc. (SNOA)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06.
What is SNOA's market cap?
Sonoma Pharmaceuticals, Inc. (SNOA) has a market capitalization of $4.73M as of 2026-06-30.
What is SNOA's EPS (earnings per share)?
Sonoma Pharmaceuticals, Inc. (SNOA)'s trailing twelve month EPS is $-0.59 as of 2026-06-30.
What is SNOA's ROE (return on equity)?
Sonoma Pharmaceuticals, Inc. (SNOA)'s trailing twelve month Return on Equity (ROE) is -42.52% as of 2026-06-30.
What is SNOA's ROA (return on assets)?
Sonoma Pharmaceuticals, Inc. (SNOA)'s trailing twelve month Return on Assets (ROA) is -13.85% as of 2026-06-30.
What is SNOA's ROIC (return on invested capital)?
Sonoma Pharmaceuticals, Inc. (SNOA)'s trailing twelve month Return on Invested Capital (ROIC) is -103.28% as of 2026-06-30.
What is SNOA's EV/EBITDA?
Sonoma Pharmaceuticals, Inc. (SNOA)'s trailing twelve month EV/EBITDA is 0.36x as of 2026-06-30.